Catherine Alix-Panabières, Director of the Human Rare Circulating Cells Laboratory (LCCRH) and University Professor at the University Hospital of Montpellier, shared a post by IHU RespirERA, adding:
“Delighted to be part of this important Conference between the MD Anderson Cancer Center and the IHU RespirERA – Liquid Biopsy will be a highlight.”
Quoting IHU RespirERA‘s post:
“5th Joint Meeting on Lung Cancer | Meet our speaker: Professor Catherine Alix-Panabières
Professor Catherine Alix-Panabières is Professor of Oncology at CHU de Montpellier and the Faculty of Medicine, where she directs the “Laboratoire de Cellules Circulantes Humaines Rares et Biopsie Liquide” (LCCRH). A pioneer in the field of circulating tumor cells (CTCs), she co-coined the term “Liquid Biopsy” in 2010 with Prof. Klaus Pantel.
With over 26 years of expertise, more than 160 scientific publications, and several international awards, her work has been instrumental in demonstrating the clinical utility of CTCs in cancer research and care.
At the 5th Joint Meeting on Lung Cancer, she will:
- Moderate the second session on October 3rd, 2025 (2:00 – 5:00 pm)
- Take part in the roundtable discussion: “Which future for NGS Liquid biopsy and for CTCs detection in Lung Cancer Patients? Powered by AstraZeneca”
October 3-4, 2025
Don’t miss the opportunity to exchange with international leaders shaping the future of lung cancer research and care.
Free registration.
Read more.”
More from Catherine Alix-Panabières on OncoDaily.